Liver Transplant Outcomes in the United States : Effect of Preservation Solution DKFC Symposium July 16, 2012 John Fung, MD, PhD Cleveland Clinic Disclosure:

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

Donors Per Million Population
WMS-IV Wechsler Memory Scale - Fourth Edition
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
OPTN HEART ALLOCATION SYSTEM DATA UPDATE Based on OPTN data as of July 16, 2010 Fall 2010 Regional Meetings.
Slide 1 Healthcare Utilization and Mortality associated with HIV and HCV: How to address the burden of liver disease Susanna Naggie 1,2, Lawrence Park.
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART TRANSPLANTATION Pediatric Recipients.
2001 J Heart Lung Transplant 2001; 20: ; 2002: 21: THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: EIGHTEENTH.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
Cost-sharing for Emergency Care and Unfavorable Clinical Events: Findings from the Safety And Financial Ramifications of ED Copayments (SAFE) Study AcademyHealth.
Jörg Drechsler (Institute for Employment Research, Germany) NTTS 2009 Brussels, 20. February 2009 Disclosure Control in Business Data Experiences with.
Epidemiology and Outcomes of IA in the 21st Century: Strengths and Weaknesses of Surveillance Databases Dionissios Neofytos, MD, MPH Transplant & Oncology.
Regression Analysis: Estimating Relationships Regression Analysis is a study of relationship between a set of independent variables and the dependent variable.
Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure PN Harden, BMJ June 2012 M Graham-Brown UHL Jan.
Happy Wednesday! April 18, What is a probability distribution? -A table or an equation that links each outcome of a statistical experiment with.
Two-sample tests. Binary or categorical outcomes (proportions) Outcome Variable Are the observations correlated?Alternative to the chi- square test if.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Chapter 17 Making Sense of Advanced Statistical Procedures in Research Articles.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
Surgery v Radiation in Prostate Cancer Prasanna Sooriakumaran MD PhD & Peter Wiklund MD PhD.
Validation of predictive regression models Ewout W. Steyerberg, PhD Clinical epidemiologist Frank E. Harrell, PhD Biostatistician.
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
David C. Mulligan, MD, FACS
Periportal Fibrosis Without Cirrhosis Does Not Affect Outcomes Following Continuous Flow Ventricular Assist Device Implantation Jonathon E. Sargent, BS,
Comparison of HTK and UW in Abdominal Transplantation Dr. Richard S. Mangus, MD MS Indiana University, School of Medicine.
Strategies for Maximizing Outcomes in Liver Transplantation James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Short and Long term function and survival of other graft harvested as part of a multiorgan procurement including the intestine Farinelli P, Troncoso J,
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Bootstrapping (And other statistical trickery). Reminder Of What We Do In Statistics Null Hypothesis Statistical Test Logic – Assume that the “no effect”
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Liver Transplantation
Research Techniques Made Simple: Multivariable Analysis Marlies Wakkee Loes Hollestein Tamar Nijsten Department of Dermatology, Erasmus University Medical.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
A CRITICAL ANALYSIS OF ORGAN PERFUSION SOLUTIONS IN LIVER TRANSPLANTATION John J. Fung, MD Director, Cleveland Clinic Health System Center for Transplantation.
DONOR RISK INDEX-LIVER GRAFT SURVIVAL ASSOCIATION IN PATIENTS OVER 18 YEARS OF AGE IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Gary L. Kamer Statistician OSB/DBS. 2 Statistical Issues at Time of PMA Review Clinical Study Design Excess All-cause Late Mortality (31 to 365 days)
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
소화기내과 김경엽 Gastroenterology 2011;140:
Chapter 9: Means and Proportions as Random Variables 9.1 Understanding dissimilarity among samples 9.2 Sampling distributions for sample proportions 9.3.
Bootstrap and Model Validation
ANZDATA Epidemiology Fellow
A Statistical Analysis Utilizing Detailed Institutional Data
Sample Size Determination
Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Non-valvular Atrial Fibrillation.
Extended Comparison of Therapeutic Treatment Outcomes of de novo Liver and Kidney Transplant Recipients with Generic Tacrolimus (Sandoz™) or Brand Name.
Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.
Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston
Donor age still matters in liver transplantation
Center Specific Outcomes Reporting
Liver only transplants in the UK Question 2: In terms of survival benefit.
HLA Compatibility and Heart Transplant Survival Using A Validated Matching Algorithm Andrew L. Rivard, MD, MS, Cleveland Clinic Abu Dhabi Naoru Koizumi,
Pancreas Transplantation Committee
Risk factors in deceased-donor transplants Risk factor 1988
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
The Research Question Aim TIA is defined by short-lasting symptoms
Recent Advances in Liver Transplantation
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pregnancy outcomes in kidney transplant recipients
Liver Transplant Data for Regional Meetings
Number of Donors in Australia
Is TCAR best under LA or GA
Presentation transcript:

Liver Transplant Outcomes in the United States : Effect of Preservation Solution DKFC Symposium July 16, 2012 John Fung, MD, PhD Cleveland Clinic Disclosure: I have been a past consultant for both Dupont and Odyssey

Recent Retrospective Database Reviews Theme of 3 studies: These results suggest that the increasing use of HTK for abdominal organ preservation should be reexamined

Liver Preservation

Indiana University, 2001 to 2008 All adult, deceased donor n=1013 HTK 632, UW 381 Simultaneous, retrospective

Liver Preservation Indiana University, 2001 to 2008 All adult, deceased donor Simultaneous, retrospective n=1013HTK 632 UW 381 Serum ALT Serum Bilirubin

Using the SRTR Database Only adult first liver-only transplants from were included and only for those whom flush and storage solutions were the same All patients had minimum one year follow up 25,616 patients, 20,901 (82%) with UW and 4,715 (18%) with HTK Mean follow-up: 2.7 ± 1.7 years (2.9 ± 1.7 for UW and 1.8 ± 1.1 for HTK)

Statistical Analysis Three comparisons: Unadjusted graft survival Bootstrapping hazard modeling using risk factors for graft survival determined using non-proportional, multiphase, multivariable hazard methodology with >100 clinically relevant recipient, donor, and procedure variables Propensity-matched comparison for 50 most important variables

Bootstrapping A random sample of patients is drawn from the original data - patients are drawn one at a time, with replacement, until a new dataset of the same size has been created When the new dataset has been created, the stepwise regression technique is run again to see what significant predictors it finds and the process is repeated multiple times The bootstrap percentage is the percent of runs in which the variable appeared, so the higher the percentage, the more certain is the impact of that variable - those appearing in >50% of runs were considered reliably statistically significant at p<0.001

Adjusting for Multiple Tests No. of independent tests Probability of one or more p < 0.05 by chance 10%23%40%64%92% To keep alpha = 0.05 accept as significant only p less than Use p = 0.05 / no. of tests

Results Validation of reported significant recipient factors of graft failure in the early and later phases after DDLT OPS did not appear as a statistically significant predictor of graft failure –hospital death, re-transplant rates and relisting rates were not different

UW n = 20,901 HTK n = 4,715 PS: p = 0.90 log rank test GS: p = 0.60 Unadjusted Patient and Graft Survival - HTK vs UW Adult LTX from

7,883 UW10,484 UW 1,826 HTK 2,314 HTK DRI 2.5: p = 0.20 Unadjusted Patient and Graft Survival - HTK vs UW Adult LTX from : By DRI - 2.5

14,053 UW6,119 UW 3,279 HTK 1,177 HTK CIT 8 hr: p = 0.50 Unadjusted Patient and Graft Survival - HTK vs UW Adult LTX from : By CIT - 8 hrs (non-DCD)

19,082 UW1,090 UW 4,253 HTK 203 HTK CIT 12 hr: p = 0.60 Unadjusted Patient and Graft Survival - HTK vs UW Adult LTX from : By CIT - 12 hrs (non-DCD)

Risk FactorPBootstrap % Early hazard phase Older recipient age (years)< Recipient race White or Black< Recipient portal vein thrombosis< Recipient previous abdominal surgery< Candidate last creatinine (used for MELD)< Candidate last MELD< Recipient on life support just prior to tx< Recipient previous kidney transplant< Donor race non-White< Donor donation after cardiac death< Donor risk index< Risk Factors for Graft Failure - Early Phase

Risk Factors for Graft Failure - Constant Phase Risk FactorPBootstrap % Late hazard phase African American recipient< Recipient primary diagnosis for tumors< Recipient hepatitis C virus< Donor age (years)< Donor history of diabetes<

Limitations of the Hopkins UNOS Analysis Used case-wise deletion of missing data, i.e. used only patients for whom all variables were reported - the actual number of cases deleted not provided Last case included was 2/28/08 - the paper was submitted on 7/17/08. Allowing a minimum of 45 days to analyze and write the paper, the latest data cutoff was 6/1/08. Using UNOS timelines for a 6/1/08 cutoff, there would only have been data for transplants performed before 11/1/07

Unadjusted 1-year Graft Survival Rates by Year of Transplant

Liver Transplant Graft Survival SRTR Data, , N=55110, Age 18+ By Years and Preservation Solution: vs and UW vs HTK SRTR Data, , N=55110, Age 18+ By Years and Preservation Solution: vs and UW vs HTK HTK UW UW HTK

Liver Transplant Patient Survival SRTR Data, , N=55110, Age 18+ By Years and Preservation Solution: vs and UW vs HTK SRTR Data, , N=55110, Age 18+ By Years and Preservation Solution: vs and UW vs HTK HTK UW UW HTK

Comparing HTK Users UNOS Report - ADDLT CenterPatient SurvivalGraft Survival United States Methodist - Memphis 92.1 (+1.0)87.4 (+0.5) University of Indiana 90.0 (+0.7)87.4 (+1.5) Cleveland Clinic91.6 (+1.7)87.9 (+1.3)

Comparing UW Users – 2010 UNOS Report - ADDLT CenterPatient SurvivalGraft Survival Johns Hopkins75.6 (-13.9)69.7 (-14.2) MUSC87.5 (-1.1)85.0 (-2.4) Univ. Pennsylvania 86.7 (-2.1)84.8 (-1.1) Univ. Wisconsin90.0 (+4.4)85.2 9(+3.7)

Conclusions Discrepancies between published reports and clinical experience: –Flawed analysis –Learning curve –Changing practices Excellent outcomes can be obtained with either solution